HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
TRAK1
trafficking kinesin protein 1
Chromosome 3 Β· 3p22.1
NCBI Gene: 22906Ensembl: ENSG00000182606.18HGNC: HGNC:29947UniProt: A0A087X0N0
64PubMed Papers
21Diseases
0Drugs
8Pathogenic Variants
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protein bindingendosome to lysosome transportmitochondrioncytoplasmgenetic developmental and epileptic encephalopathycancergenetic disorderundetermined early-onset epileptic encephalopathy
✦AI Summary

TRAK1 (trafficking kinesin protein 1) is a mitochondrial adapter protein essential for neuronal function and development. Primary Function: TRAK1 serves as a core scaffold linking mitochondria to the microtubule transport machinery. It directly interacts with MIRO1 on the outer mitochondrial membrane and recruits kinesin-1 and dynein-dynactin motors to enable anterograde and retrograde mitochondrial transport along axons 12. Additionally, TRAK1 regulates endosome-to-lysosome trafficking, including EGFR and GABA-A receptor internalization [PMID:18675823 via UniProt]. Mechanism: TRAK1 forms a dimeric complex with MIRO1 through two distinct binding sites, independent of calcium or nucleotide conditions 2. It also interacts with mitofusins to promote mitochondrial tethering and fusion 3, and associates with DISC1 interactors NDE1 and GSK3Ξ² to regulate axonal mitochondrial motility 4. Disease Relevance: Homozygous truncating TRAK1 variants cause developmental and epileptic encephalopathy 68, manifesting as severe neurodegeneration with defective mitochondrial distribution, reduced membrane potential, and impaired respiration 5. Variants are also linked to childhood absence epilepsy and intellectual disability 6. Clinical Significance: TRAK1 dysfunction impairs critical mitochondrial delivery to high-energy neuronal sites, contributing to neurodegeneration; enhancing TRAK1-mediated mitochondrial transport shows neuroprotective potential in ischemic stroke 78.

Sources cited
1
MIRO1-TRAK1 interaction mechanism and binding site characterization with low micromolar affinity
PMID: 37949220
2
Cryo-EM structure and characterization of MIRO1-TRAK1 complex with dual binding sites
PMID: 40615373
3
TRAK1 function in mitochondrial fusion via interaction with mitofusins; hypertonia-associated mutation impairs mitochondrial localization
PMID: 28924745
4
TRAK1 association with NDE1 and GSK3Ξ² in regulation of axonal mitochondrial motility
PMID: 26815013
5
Homozygous truncating TRAK1 variants cause fatal encephalopathy with defective mitochondrial dynamics
PMID: 28364549
6
TRAK1 variants confirmed as disease-gene links for intellectual disability
PMID: 28940097
7
TRAK1 involvement in astrocyte-mediated mitochondrial transfer and neuroprotection in ischemic stroke
PMID: 40598228
8
OPTN interaction with TRAK1/KIF5B complex for axonal mitochondrial transport and neuroprotection
PMID: 39979261
Disease Associationsβ“˜21
genetic developmental and epileptic encephalopathyOpen Targets
0.61Moderate
cancerOpen Targets
0.54Moderate
genetic disorderOpen Targets
0.42Moderate
undetermined early-onset epileptic encephalopathyOpen Targets
0.37Weak
Abnormality of the skeletal systemOpen Targets
0.30Weak
heart failureOpen Targets
0.28Weak
bipolar disorderOpen Targets
0.28Weak
head and neck malignant neoplasiaOpen Targets
0.25Weak
smoking initiationOpen Targets
0.22Weak
HypertoniaOpen Targets
0.08Suggestive
epilepsyOpen Targets
0.05Suggestive
Young adult-onset ParkinsonismOpen Targets
0.05Suggestive
Spinocerebellar ataxia type 40Open Targets
0.05Suggestive
infantile-onset generalized dyskinesia with orofacial involvementOpen Targets
0.05Suggestive
spinocerebellar ataxia type 15/16Open Targets
0.05Suggestive
attention deficit hyperactivity disorderOpen Targets
0.05Suggestive
developmental disabilityOpen Targets
0.05Suggestive
atypical juvenile parkinsonismOpen Targets
0.05Suggestive
Alzheimer diseaseOpen Targets
0.05Suggestive
spinocerebellar ataxia type 35Open Targets
0.05Suggestive
Developmental and epileptic encephalopathy 68UniProt
Pathogenic Variants8
NM_001042646.3(TRAK1):c.52_62dup (p.His21fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 21
NM_001042646.3(TRAK1):c.91+1G>ALikely pathogenic
not provided
β˜…β˜†β˜†β˜†2025
NM_001042646.3(TRAK1):c.52_62del (p.Gly18fs)Likely pathogenic
Developmental and epileptic encephalopathy, 68
β˜…β˜†β˜†β˜†2023β†’ Residue 18
NM_001042646.3(TRAK1):c.286+1G>APathogenic
not provided|Uterine corpus endometrial carcinoma
β˜…β˜†β˜†β˜†2021
NM_001042646.3(TRAK1):c.1412_1413del (p.Glu471fs)Pathogenic
Inborn genetic diseases
β˜…β˜†β˜†β˜†2017β†’ Residue 471
NM_001042646.3(TRAK1):c.1759dup (p.His587fs)Pathogenic
Developmental and epileptic encephalopathy, 68
β˜†β˜†β˜†β˜†2021β†’ Residue 587
NM_001042646.3(TRAK1):c.287-2A>GPathogenic
Developmental and epileptic encephalopathy, 68
β˜†β˜†β˜†β˜†2020
NM_001042646.3(TRAK1):c.287-2A>CPathogenic
Developmental and epileptic encephalopathy, 68
β˜†β˜†β˜†β˜†2020
View on ClinVar β†—
Related Genes
MFN2Protein interaction100%RHOT2Protein interaction100%DISC1Protein interaction98%PINK1Protein interaction97%MFN1Protein interaction96%MYO19Protein interaction95%
Tissue Expression6 tissues
Heart
100%
Brain
23%
Lung
20%
Bone Marrow
16%
Liver
11%
Ovary
7%
Gene Interaction Network
Click a node to explore
TRAK1MFN2RHOT2DISC1PINK1MFN1MYO19
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt Q9UPV9
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
0.46Moderately Constrained
pLIβ“˜
1.00Intolerant
Observed/Expected LoF0.34 [0.25–0.46]
RankingsWhere TRAK1 stands among ~20K protein-coding genes
  • #7,324of 20,598
    Most Researched64
  • #3,075of 5,498
    Most Pathogenic Variants8
  • #2,611of 17,882
    Most Constrained (LOEUF)0.46 Β· top quartile
Genes detectedTRAK1
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Expanding the genetic heterogeneity of intellectual disability.
PMID: 28940097
Hum Genet Β· 2017
1.00
2
Mechanisms of electroacupuncture-induced neuroprotection in acute stroke rats: the role of astrocyte-mediated mitochondrial transfer.
PMID: 40598228
Cell Commun Signal Β· 2025
0.90
3
Optineurin-facilitated axonal mitochondria delivery promotes neuroprotection and axon regeneration.
PMID: 39979261
Nat Commun Β· 2025
0.80
4
Interaction between the mitochondrial adaptor MIRO and the motor adaptor TRAK.
PMID: 37949220
J Biol Chem Β· 2023
0.70
5
Structural-functional characterization of the MIRO1-TRAK1 complex.
PMID: 40615373
Nat Commun Β· 2025
0.60